Cosmetic peptides

Cosmetic peptides are formulated for topical use in skin and hair products rather than systemic administration. The category includes SNARE-targeting sequences marketed for expression lines, copper-binding tripeptides, and signal peptides used in collagen research. Systemic pharmacokinetics is usually not established because these are not intended to be absorbed.

26 profiles in this category. Browse all peptides. Research use only. Not medical advice.

Cosmetic peptides (26)

CosmeticExperimental

Cosmetic • Cosmetic SNARE-targeting peptide • Experimental

Topical hexapeptide (Argireline) used in cosmetics as a SNAP-25 fragment analog. Marketed to soften expression lines; not an FDA-approved drug.

Mechanism: Acetyl hexapeptide-8, commonly sold as Argireline, mimics…

Half-life: Topical; systemic PK not established

MW:

CosmeticExperimental

Cosmetic • Cosmetic SNARE-targeting peptide • Experimental

Elongated Argireline analog (SNAP-8) used in topical cosmetics. Not an FDA-approved drug; not WADA-prohibited as a cosmetic peptide.

Mechanism: Acetyl octapeptide-3, sold as SNAP-8, is an elongated ana…

Half-life: Topical; systemic PK not established

MW: ≈1075.2 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic hair and skin matrikine • Experimental

Short acetylated tetrapeptide used topically in hair-density and skin-firmness formulations, commonly paired with red clover extract in commercial blends. Regulated as a cosmetic ingredient, not FDA-approved as a drug.

Mechanism: Acetyl tetrapeptide-3 is described as a matrikine — a pep…

MW: 509.6 g/mol

Cosmetic

Cosmetic • FDA-approved α-MSH analog • Established

FDA-approved α-MSH analog implant (SCENESSE) to increase pain-free light exposure in adults with erythropoietic protoporphyria. 16 mg subcutaneous implant every 2 months.

Mechanism: Afamelanotide is a synthetic analog of alpha-melanocyte-s…

Half-life: ~30 minutes (plasma); ~15 h (from implant)

MW: 1646.9 g/mol

NEW
CosmeticExperimental

Cosmetic • Copper tripeptide / cosmetic research • Experimental

Alanine-histidine-lysine copper complex used in hair- and skin-cosmetic research, related to GHK-Cu. Not an FDA-approved drug.

Mechanism: AHK-Cu is the copper complex of the tripeptide alanyl-his…

MW: 451.39 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic hair peptide • Experimental

Biotin-conjugated tripeptide used in topical hair and lash products, typically as part of proprietary blends. Not FDA-approved as a drug; regulated as a cosmetic ingredient.

Mechanism: The peptide couples biotin to the GHK tripeptide, which h…

MW: 566.7 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic tyrosinase-inhibiting peptide • Experimental

Synthetic decapeptide used topically in pigmentation products as a non-hydroquinone alternative. Regulated as a cosmetic ingredient; not FDA-approved as a drug.

Mechanism: Decapeptide-12 was identified by screening for peptides t…

MW: 1395.5 g/mol

CosmeticExperimental

Cosmetic • Cosmetic nicotinic antagonist mimetic • Experimental

Waglerin-1–inspired tripeptide used in cosmetics to reduce expression-line appearance. Topical cosmetic active, not an FDA drug.

Mechanism: This dipeptide is a synthetic mimetic of waglerin-1, a co…

Half-life: Topical; systemic PK not established

MW:

Muscle/RecoveryCosmeticExperimental

Muscle/Recovery • Copper tripeptide / cosmetic and research • Experimental

Endogenous glycyl-L-histidyl-L-lysine copper complex used widely in cosmetics for skin remodeling. Injectable research use is unapproved. USADA lists GHK (tripeptide-1) as not prohibited.

Mechanism: GHK is a naturally occurring tripeptide (glycyl-L-histidy…

Half-life: Short; typically used topically

MW: 403.92 g/mol

Muscle/RecoveryCosmeticExperimental

Muscle/Recovery • Regenerative-cosmetic blend • Experimental

Vendor blend typically combining GHK-Cu, BPC-157, and TB-500 for cosmetic/regenerative research. Not a single API; BPC-157 and TB-500 are WADA issues if the blend contains them.

Mechanism: Glow is a compounded blend rather than a single compound,…

Half-life: Varies by component

MW: Varies

LongevityCosmeticExperimental

Longevity • Endogenous tripeptide antioxidant • Experimental

Endogenous antioxidant tripeptide sold as an oral supplement and used IV in clinics. Not FDA-approved as a standalone drug for systemic “detox” or skin-lightening claims.

Mechanism: Glutathione is a tripeptide of glutamate, cysteine and gl…

Half-life: ~1.5 hours (IV); oral bioavailability limited

MW: 307.32 g/mol

Muscle/RecoveryCosmeticExperimental

Muscle/Recovery • Regenerative blend • Experimental

Vendor regenerative blend (commonly BPC-157, TB-500, GHK-Cu, and KPV). Not a single drug; several components are WADA-prohibited or unapproved.

Mechanism: KLOW is a compounded blend of GHK-Cu, KPV, BPC-157 and TB…

Half-life: Varies

MW: Varies

KPV

CosmeticExperimental

Cosmetic • Anti-inflammatory MSH fragment / research • Experimental

C-terminal α-MSH tripeptide with anti-inflammatory activity in gut and skin models without strong melanotropic tanning. Not FDA-approved.

Mechanism: KPV is Lys-Pro-Val, the C-terminal tripeptide of alpha-me…

Half-life: Short; topical and research injectable use

MW: 342.44 g/mol

CosmeticExperimental

Cosmetic • Human cathelicidin / research • Experimental

Human host-defense peptide (cathelicidin) with antimicrobial and immunomodulatory activity. Not FDA-approved as a drug; excess LL-37 is implicated in rosacea/psoriasis biology.

Mechanism: LL-37 is the only human cathelicidin, released by proteol…

Half-life: ~1-2 hours

MW: 4493 Da

CosmeticExperimental

Cosmetic • Unapproved melanocortin agonist • Experimental

Cyclic α-MSH analog used illicitly for tanning and libido. Not FDA-approved. FDA and EMA have warned against its use. WADA S0 as a non-approved substance.

Mechanism: Melanotan II is a cyclic lactam analog of alpha-melanocyt…

Half-life: ~36 hours

MW: 1024.2 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic lash and brow peptide • Experimental

Lipidated pentapeptide used in eyelash and eyebrow conditioning products. Regulated as a cosmetic ingredient; not FDA-approved as a drug and not equivalent to prostaglandin analog lash treatments.

Mechanism: Attachment of a myristoyl fatty acid chain increases lipo…

MW: 796.1 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic matrikine • Experimental

Palmitoylated hexapeptide used in topical anti-ageing formulations, frequently combined with other matrikines. Regulated as a cosmetic ingredient; not FDA-approved as a drug.

Mechanism: The peptide portion corresponds to a repeating motif of e…

MW: 737 g/mol

CosmeticExperimental

Cosmetic • Cosmetic matrikine • Experimental

Palmitoylated KTTKS matrikine (Matrixyl) used in anti-wrinkle cosmetics. Not an FDA drug. Not WADA-prohibited as a cosmetic peptide.

Mechanism: Palmitoyl pentapeptide-4 is the KTTKS sequence, a fragmen…

Half-life: Topical; systemic PK not established

MW: ≈802.07 g/mol

CosmeticExperimental

Cosmetic • Cosmetic matrikine • Experimental

Palmitoylated GQPR tetrapeptide used to reduce IL-6 in stressed skin models and paired with pal-tripeptide-1 in Matrixyl 3000.

Mechanism: Palmitoyl tetrapeptide-7 is a short peptide with a palmit…

Half-life: Topical; systemic PK not established

MW: ≈694.9 g/mol

CosmeticExperimental

Cosmetic • Cosmetic copper-free GHK analog • Experimental

The GHK tripeptide supplied with a palmitic acid chain attached to improve penetration through the outer skin barrier, and without the bound copper of GHK-Cu. It is used topically as a matrikine, a peptide fragment that signals matrix turnover to dermal fibroblasts, and is most often formulated alongside palmitoyl tetrapeptide-7. Regulated as a cosmetic ingredient rather than a drug, and not FDA-approved for any therapeutic use.

Mechanism: Palmitoyl tripeptide-1 delivers the GHK sequence with a s…

Half-life: Topical; systemic PK not established

MW: ≈578.8 g/mol

CosmeticExperimental

Cosmetic • Cosmetic TGF-β mimetic tripeptide • Experimental

Lipidated tripeptide marketed under the Syn-Coll name and used topically in firming and anti-ageing formulations. It is described as a thrombospondin-1 mimetic, intended to promote activation of transforming growth factor beta already present in the dermis rather than to supply new growth factor. Evidence comes predominantly from supplier research and small cosmetic studies. A cosmetic active, not a drug, and not FDA-approved.

Mechanism: Palmitoyl tripeptide-5 is a lipidated tripeptide used top…

Half-life: Topical; systemic PK not established

MW:

NEW
CosmeticExperimental

Cosmetic • Hair-follicle Wnt research peptide • Experimental

Cell-penetrating peptide designed to block CXXC5–Dishevelled binding and enhance Wnt signaling in hair-growth mouse models. Not FDA-approved.

Mechanism: PTD-DBM is a fusion of a protein transduction domain, whi…

MW: 3082.6 g/mol

CosmeticExperimental

Cosmetic • Cosmetic EGF / research • Experimental

Recombinant or fragment EGF used in cosmetics as sh-oligopeptide-1. Topical cosmetic; injectable EGF is a different, unapproved proposition.

Mechanism: Human epidermal growth factor is a 53-amino-acid protein …

Half-life: Topical; systemic PK not applicable

MW: ≈6.2 kDa (protein growth factor)

Muscle/RecoveryCosmeticExperimental

Muscle/Recovery • Actin-sequestering peptide / research • Experimental

43-aa G-actin-sequestering peptide studied for wound healing and cardiac repair (timbetasin programs). Not FDA-approved. Distinct from the shorter TB-500 fragment.

Mechanism: Thymosin beta-4 is a 43-amino-acid peptide and the princi…

Half-life: Not well established in humans

MW: ≈4963 g/mol

NEW
CosmeticExperimental

Cosmetic • Cosmetic firming peptide • Experimental

Fluorinated tripeptide marketed in topical firming products, sold commercially under the Progeline name. Regulated as a cosmetic ingredient; not FDA-approved as a drug.

Mechanism: Supplier research describes inhibition of progerin, a tru…

MW: 475.5 g/mol

NEW
CosmeticExperimental

Cosmetic • Zinc-bound thymic nonapeptide / research • Experimental

Zinc-complexed form of thymulin, the thymic nonapeptide that requires bound zinc for biological activity. Investigated for immune modulation and, topically, for hair growth. Not FDA-approved.

Mechanism: Thymulin is biologically inactive without a bound zinc io…